Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marissa N D Lassere

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Journal of Clinical Epidemiology|September 2, 2024
Surrogate endpoint metaregression: useful statistics for regulators and trialistsStuart G Baker, Marissa N D Lassere, Wang Pok Lo
JBI Evidence Implementation|February 11, 2021
Bias, coverage, and asymptotic behaviour of random effects meta-analysis: a clinically driven simulation studyKent Johnson, Andrew Hayen, Marissa N D Lassere, et al.
Journal of Clinical Epidemiology|October 7, 2008
LDL-cholesterol differences predicted survival benefit in statin trials by the surrogate threshold effect (STE)Kent R Johnson, Nick Freemantle, Danielle M Anthony, et al.
The Journal of Rheumatology|October 6, 2005
Generic patient self-report and investigator report instruments of therapeutic safety and tolerabilityMarissa N D Lassere, Kent R Johnson, Susanne Van Santen, et al.
The Journal of Rheumatology|October 6, 2005
Challenges and progress in adverse event ascertainment and reporting in clinical trialsMarissa N D Lassere, Kent R Johnson, Thasia G Woodworth, et al.
The Journal of Rheumatology|December 7, 2005
The evidence for magnetic resonance imaging as an outcome measure in proof-of-concept rheumatoid arthritis studiesPhilip G Conaghan, Fiona M McQueen, Charles G Peterfy, et al.
The Journal of Rheumatology|December 7, 2005
Magnetic resonance imaging in rheumatoid arthritis advances and research prioritiesMikkel Ostergaard, Fiona M McQueen, Paul Bird, et al.
The Journal of Rheumatology|October 6, 2005
Standardized assessment of adverse events in rheumatology clinical trials: summary of the OMERACT 7 drug safety module updateMarissa N D Lassere, Kent R Johnson, Maarten Boers, et al.
The Journal of Rheumatology|December 7, 2005
Musculoskeletal ultrasound including definitions for ultrasonographic pathologyRichard J Wakefield, Peter V Balint, Marcin Szkudlarek, et al.
The Journal of Rheumatology|October 6, 2005
Minimal disease activity for rheumatoid arthritis: a preliminary definitionGeorge A Wells, Maarten Boers, Beverley Shea, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Journal of Clinical Epidemiology|September 2, 2024
Surrogate endpoint metaregression: useful statistics for regulators and trialistsStuart G Baker, Marissa N D Lassere, Wang Pok Lo
JBI Evidence Implementation|February 11, 2021
Bias, coverage, and asymptotic behaviour of random effects meta-analysis: a clinically driven simulation studyKent Johnson, Andrew Hayen, Marissa N D Lassere, et al.
Journal of Clinical Epidemiology|October 7, 2008
LDL-cholesterol differences predicted survival benefit in statin trials by the surrogate threshold effect (STE)Kent R Johnson, Nick Freemantle, Danielle M Anthony, et al.
The Journal of Rheumatology|October 6, 2005
Generic patient self-report and investigator report instruments of therapeutic safety and tolerabilityMarissa N D Lassere, Kent R Johnson, Susanne Van Santen, et al.
The Journal of Rheumatology|October 6, 2005
Challenges and progress in adverse event ascertainment and reporting in clinical trialsMarissa N D Lassere, Kent R Johnson, Thasia G Woodworth, et al.
The Journal of Rheumatology|December 7, 2005
The evidence for magnetic resonance imaging as an outcome measure in proof-of-concept rheumatoid arthritis studiesPhilip G Conaghan, Fiona M McQueen, Charles G Peterfy, et al.
The Journal of Rheumatology|December 7, 2005
Magnetic resonance imaging in rheumatoid arthritis advances and research prioritiesMikkel Ostergaard, Fiona M McQueen, Paul Bird, et al.
The Journal of Rheumatology|October 6, 2005
Standardized assessment of adverse events in rheumatology clinical trials: summary of the OMERACT 7 drug safety module updateMarissa N D Lassere, Kent R Johnson, Maarten Boers, et al.
The Journal of Rheumatology|December 7, 2005
Musculoskeletal ultrasound including definitions for ultrasonographic pathologyRichard J Wakefield, Peter V Balint, Marcin Szkudlarek, et al.
The Journal of Rheumatology|October 6, 2005
Minimal disease activity for rheumatoid arthritis: a preliminary definitionGeorge A Wells, Maarten Boers, Beverley Shea, et al.
Pageof 1